

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 5.73473144 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.61802518 |
| 3 | presynaptic membrane organization (GO:0097090) | 5.47842006 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.37781697 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.34546004 |
| 6 | protein localization to synapse (GO:0035418) | 5.14867108 |
| 7 | protein-cofactor linkage (GO:0018065) | 4.94843968 |
| 8 | layer formation in cerebral cortex (GO:0021819) | 4.90577385 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.89114200 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.80186154 |
| 11 | glutamate secretion (GO:0014047) | 4.75882954 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.74405732 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.58969778 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.52824134 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.52528372 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.50016084 |
| 17 | positive regulation of synapse maturation (GO:0090129) | 4.40108004 |
| 18 | vocalization behavior (GO:0071625) | 4.36162701 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.21385210 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.13642175 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.09367017 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.08311434 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.02966760 |
| 24 | neuron recognition (GO:0008038) | 3.88038369 |
| 25 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.81969453 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 3.66034077 |
| 27 | proline transport (GO:0015824) | 3.56780656 |
| 28 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.55567748 |
| 29 | behavioral response to ethanol (GO:0048149) | 3.55541372 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.55019912 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.52032407 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51760316 |
| 33 | synaptic vesicle endocytosis (GO:0048488) | 3.50452334 |
| 34 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.50131309 |
| 35 | cell migration in hindbrain (GO:0021535) | 3.50079283 |
| 36 | regulation of synapse maturation (GO:0090128) | 3.49998857 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.48628639 |
| 38 | axonal fasciculation (GO:0007413) | 3.48413691 |
| 39 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.46038233 |
| 40 | exploration behavior (GO:0035640) | 3.43832837 |
| 41 | locomotory exploration behavior (GO:0035641) | 3.42491430 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.41757108 |
| 43 | neurotransmitter transport (GO:0006836) | 3.39674135 |
| 44 | mating behavior (GO:0007617) | 3.39654823 |
| 45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37289201 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.37231802 |
| 47 | negative regulation of microtubule polymerization (GO:0031115) | 3.34239100 |
| 48 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.32992195 |
| 49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.32051680 |
| 50 | positive regulation of mitochondrial fission (GO:0090141) | 3.28194806 |
| 51 | prepulse inhibition (GO:0060134) | 3.27837697 |
| 52 | regulation of vesicle fusion (GO:0031338) | 3.25324665 |
| 53 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.23670554 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.22763757 |
| 55 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21379694 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.18223380 |
| 57 | synapse assembly (GO:0007416) | 3.17553159 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.17016670 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.13753258 |
| 60 | nonmotile primary cilium assembly (GO:0035058) | 3.13482956 |
| 61 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12950159 |
| 62 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.12910674 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.12545886 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.11722391 |
| 65 | regulation of neurotransmitter transport (GO:0051588) | 3.11644296 |
| 66 | neuromuscular process controlling posture (GO:0050884) | 3.10298942 |
| 67 | response to histamine (GO:0034776) | 3.08957412 |
| 68 | nucleobase catabolic process (GO:0046113) | 3.08941262 |
| 69 | protein neddylation (GO:0045116) | 3.08391559 |
| 70 | synaptic transmission, glutamatergic (GO:0035249) | 3.08302650 |
| 71 | mitochondrion transport along microtubule (GO:0047497) | 3.08129531 |
| 72 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.08129531 |
| 73 | detection of calcium ion (GO:0005513) | 3.07051355 |
| 74 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.06778427 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06679783 |
| 76 | righting reflex (GO:0060013) | 3.06302932 |
| 77 | long-term memory (GO:0007616) | 3.06200205 |
| 78 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.06059862 |
| 79 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.06059862 |
| 80 | organelle transport along microtubule (GO:0072384) | 3.05220803 |
| 81 | vesicle transport along microtubule (GO:0047496) | 3.05056990 |
| 82 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.04450711 |
| 83 | innervation (GO:0060384) | 3.03867700 |
| 84 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.02100850 |
| 85 | establishment of synaptic vesicle localization (GO:0097480) | 3.02047342 |
| 86 | synaptic vesicle transport (GO:0048489) | 3.02047342 |
| 87 | establishment of mitochondrion localization (GO:0051654) | 3.01402831 |
| 88 | neurofilament cytoskeleton organization (GO:0060052) | 3.01354780 |
| 89 | axon cargo transport (GO:0008088) | 3.01330690 |
| 90 | negative regulation of dendrite development (GO:2000171) | 3.01295291 |
| 91 | regulation of postsynaptic membrane potential (GO:0060078) | 3.01091969 |
| 92 | response to pheromone (GO:0019236) | 2.98229612 |
| 93 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.98223030 |
| 94 | behavioral response to cocaine (GO:0048148) | 2.97117810 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.96321886 |
| 96 | membrane depolarization during action potential (GO:0086010) | 2.94376385 |
| 97 | synaptic transmission, dopaminergic (GO:0001963) | 2.94018252 |
| 98 | DNA damage response, detection of DNA damage (GO:0042769) | 2.92820072 |
| 99 | striatum development (GO:0021756) | 2.92462395 |
| 100 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.91552223 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 2.90718261 |
| 102 | dopamine receptor signaling pathway (GO:0007212) | 2.90714872 |
| 103 | establishment of vesicle localization (GO:0051650) | 2.89302024 |
| 104 | synaptic transmission (GO:0007268) | 2.89042061 |
| 105 | neuromuscular synaptic transmission (GO:0007274) | 2.87795451 |
| 106 | transmission of nerve impulse (GO:0019226) | 2.87120357 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.86139794 |
| 108 | response to auditory stimulus (GO:0010996) | 2.86043179 |
| 109 | cerebellar granule cell differentiation (GO:0021707) | 2.85413721 |
| 110 | postsynaptic membrane organization (GO:0001941) | 2.84022063 |
| 111 | membrane assembly (GO:0071709) | 2.73028542 |
| 112 | DNA double-strand break processing (GO:0000729) | 2.71671560 |
| 113 | L-serine metabolic process (GO:0006563) | 2.69651431 |
| 114 | eosinophil chemotaxis (GO:0048245) | 2.66898321 |
| 115 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.66032755 |
| 116 | IMP biosynthetic process (GO:0006188) | 2.60786042 |
| 117 | otic vesicle formation (GO:0030916) | 2.58952498 |
| 118 | negative regulation of DNA recombination (GO:0045910) | 2.58695456 |
| 119 | positive regulation of synapse assembly (GO:0051965) | 2.57570284 |
| 120 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.54996077 |
| 121 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.54996077 |
| 122 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.54996077 |
| 123 | establishment of integrated proviral latency (GO:0075713) | 2.53924947 |
| 124 | regulation of gene silencing by RNA (GO:0060966) | 2.52477622 |
| 125 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.52477622 |
| 126 | regulation of gene silencing by miRNA (GO:0060964) | 2.52477622 |
| 127 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.48946696 |
| 128 | termination of RNA polymerase III transcription (GO:0006386) | 2.48537462 |
| 129 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.48537462 |
| 130 | behavioral response to nicotine (GO:0035095) | 2.46644390 |
| 131 | dicarboxylic acid catabolic process (GO:0043649) | 2.45482510 |
| 132 | neuronal action potential (GO:0019228) | 2.44763911 |
| 133 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.41776973 |
| 134 | ATP synthesis coupled proton transport (GO:0015986) | 2.41776973 |
| 135 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.41261059 |
| 136 | chaperone-mediated protein transport (GO:0072321) | 2.38655021 |
| 137 | neurotransmitter uptake (GO:0001504) | 2.38506241 |
| 138 | eosinophil migration (GO:0072677) | 2.37781077 |
| 139 | regulation of synapse assembly (GO:0051963) | 2.37397493 |
| 140 | retinal cone cell development (GO:0046549) | 2.35702959 |
| 141 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.35425399 |
| 142 | paraxial mesoderm development (GO:0048339) | 2.35374466 |
| 143 | neurotransmitter biosynthetic process (GO:0042136) | 2.34765260 |
| 144 | telomere maintenance via telomerase (GO:0007004) | 2.32360378 |
| 145 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.31808754 |
| 146 | IMP metabolic process (GO:0046040) | 2.30464346 |
| 147 | negative regulation of sister chromatid segregation (GO:0033046) | 2.28321192 |
| 148 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.28321192 |
| 149 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.28321192 |
| 150 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.28321192 |
| 151 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.28321192 |
| 152 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.27676784 |
| 153 | kidney morphogenesis (GO:0060993) | 2.27512971 |
| 154 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.26684973 |
| 155 | synapse organization (GO:0050808) | 2.26379288 |
| 156 | regulation of meiosis I (GO:0060631) | 2.26226918 |
| 157 | C4-dicarboxylate transport (GO:0015740) | 2.26220223 |
| 158 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.25228117 |
| 159 | negative regulation of membrane potential (GO:0045837) | 2.22505714 |
| 160 | limb bud formation (GO:0060174) | 2.21972817 |
| 161 | anterior/posterior axis specification, embryo (GO:0008595) | 2.21622534 |
| 162 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.21364637 |
| 163 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.21364637 |
| 164 | regulation of helicase activity (GO:0051095) | 2.20314644 |
| 165 | regulation of cilium movement (GO:0003352) | 2.17209389 |
| 166 | negative regulation of chromosome segregation (GO:0051985) | 2.16206553 |
| 167 | succinate metabolic process (GO:0006105) | 2.16043190 |
| 168 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.16013398 |
| 169 | regulation of sarcomere organization (GO:0060297) | 2.14880615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.60357367 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77693133 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98650792 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95752679 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.93753206 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.90739164 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81981829 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.75067536 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58778187 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55946438 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54041575 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54041575 |
| 13 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53466450 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.49657357 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43441268 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41189924 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.37444079 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34536828 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.34249295 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34139264 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32365994 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26917545 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20741954 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16791317 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12840308 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.09446150 |
| 27 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08657491 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.06882689 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.03247436 |
| 30 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.01394192 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00431329 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99470010 |
| 33 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98893087 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.95846056 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90433617 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.90343612 |
| 37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87997854 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.87516621 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79252357 |
| 40 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.77644325 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.76507904 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.75807841 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73704709 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69943557 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68561052 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67394997 |
| 47 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62893909 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61590367 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60859959 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57178692 |
| 51 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.56593332 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54255535 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54161346 |
| 54 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.52465785 |
| 55 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52436195 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50868857 |
| 57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48954315 |
| 58 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47335383 |
| 59 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.46901007 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45746151 |
| 61 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.45204824 |
| 62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44582613 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43792326 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43144211 |
| 65 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41938192 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41886353 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41602348 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41294990 |
| 69 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41195394 |
| 70 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.39705088 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37209077 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36312074 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.35555899 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33532484 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32474766 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31672646 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30871854 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26114036 |
| 79 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24974029 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24970933 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24830390 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24676546 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22896770 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21836683 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21474353 |
| 86 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.20919962 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20436411 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19095154 |
| 89 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17840629 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15958682 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14337016 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12917493 |
| 93 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12406661 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11925964 |
| 95 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.11568991 |
| 96 | JUN_21703547_ChIP-Seq_K562_Human | 1.10602998 |
| 97 | AR_19668381_ChIP-Seq_PC3_Human | 1.10403963 |
| 98 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10387566 |
| 99 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10271614 |
| 100 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.09864551 |
| 101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09709371 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09203472 |
| 103 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07300178 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06269692 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05889696 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05297653 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05047786 |
| 108 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04441493 |
| 109 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03515003 |
| 110 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.03456440 |
| 111 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03314755 |
| 112 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02544117 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02329419 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01095939 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00875230 |
| 116 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00875230 |
| 117 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00875230 |
| 118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00308645 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00032895 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00032895 |
| 121 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99366131 |
| 122 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99031494 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99026687 |
| 124 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98765434 |
| 125 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98126048 |
| 126 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.97834499 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97456208 |
| 128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96741136 |
| 129 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96451090 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96451090 |
| 131 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.95917993 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95487170 |
| 133 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95464729 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95130836 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94644459 |
| 136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94060827 |
| 137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93971064 |
| 138 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93865284 |
| 139 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93773156 |
| 140 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92900751 |
| 141 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92799030 |
| 142 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91573847 |
| 143 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91402285 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90772133 |
| 145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90600210 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90344166 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89716608 |
| 148 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88354194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.40789253 |
| 2 | MP0003880_abnormal_central_pattern | 4.18528017 |
| 3 | MP0004270_analgesia | 3.69781088 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.45655282 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.11745046 |
| 6 | MP0009046_muscle_twitch | 3.07627455 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.04692232 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.01649439 |
| 9 | MP0009745_abnormal_behavioral_response | 2.80852191 |
| 10 | MP0001984_abnormal_olfaction | 2.80562551 |
| 11 | MP0002822_catalepsy | 2.78558868 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.70860076 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.68365076 |
| 14 | MP0003941_abnormal_skin_development | 2.63031116 |
| 15 | MP0002064_seizures | 2.58612120 |
| 16 | MP0002272_abnormal_nervous_system | 2.43949331 |
| 17 | MP0002736_abnormal_nociception_after | 2.43786028 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.42945757 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.39816505 |
| 20 | MP0002184_abnormal_innervation | 2.34544786 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.26880439 |
| 22 | MP0001970_abnormal_pain_threshold | 2.20941041 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.19474054 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.17454063 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.12391444 |
| 26 | MP0001486_abnormal_startle_reflex | 2.11974687 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.10551817 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.08926357 |
| 29 | MP0001529_abnormal_vocalization | 2.08717479 |
| 30 | MP0006292_abnormal_olfactory_placode | 2.01685273 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 2.00605642 |
| 32 | MP0000778_abnormal_nervous_system | 1.91602172 |
| 33 | MP0004858_abnormal_nervous_system | 1.91283890 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.81376353 |
| 35 | MP0004924_abnormal_behavior | 1.81376353 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.75021267 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.73256669 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.69518675 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.61395796 |
| 40 | MP0008569_lethality_at_weaning | 1.59087478 |
| 41 | MP0000751_myopathy | 1.59048869 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.58208121 |
| 43 | MP0008058_abnormal_DNA_repair | 1.58041822 |
| 44 | MP0000955_abnormal_spinal_cord | 1.56921054 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.56247271 |
| 46 | MP0003329_amyloid_beta_deposits | 1.55798333 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.51778088 |
| 48 | MP0001905_abnormal_dopamine_level | 1.50405304 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.50217481 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.49269056 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.46534203 |
| 52 | MP0005499_abnormal_olfactory_system | 1.43497004 |
| 53 | MP0005394_taste/olfaction_phenotype | 1.43497004 |
| 54 | MP0003646_muscle_fatigue | 1.43404957 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.42479262 |
| 56 | MP0003122_maternal_imprinting | 1.41683791 |
| 57 | MP0003787_abnormal_imprinting | 1.40751703 |
| 58 | MP0003879_abnormal_hair_cell | 1.36592105 |
| 59 | MP0003123_paternal_imprinting | 1.35708190 |
| 60 | MP0001188_hyperpigmentation | 1.34424595 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.31473475 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.29837594 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.26368989 |
| 64 | MP0000749_muscle_degeneration | 1.24937378 |
| 65 | MP0001293_anophthalmia | 1.22734779 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.21692333 |
| 67 | MP0003136_yellow_coat_color | 1.21359771 |
| 68 | MP0002229_neurodegeneration | 1.19959870 |
| 69 | MP0002233_abnormal_nose_morphology | 1.17787553 |
| 70 | MP0004142_abnormal_muscle_tone | 1.16215222 |
| 71 | MP0004233_abnormal_muscle_weight | 1.16171784 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.15550387 |
| 73 | MP0002752_abnormal_somatic_nervous | 1.15091793 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 1.14743689 |
| 75 | MP0009672_abnormal_birth_weight | 1.12832418 |
| 76 | MP0002638_abnormal_pupillary_reflex | 1.10328858 |
| 77 | MP0003385_abnormal_body_wall | 1.08570766 |
| 78 | MP0002160_abnormal_reproductive_system | 1.05425511 |
| 79 | MP0008872_abnormal_physiological_respon | 1.04653556 |
| 80 | MP0004742_abnormal_vestibular_system | 1.04375540 |
| 81 | MP0003119_abnormal_digestive_system | 1.04209694 |
| 82 | MP0002090_abnormal_vision | 1.04189201 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.99961424 |
| 84 | MP0002152_abnormal_brain_morphology | 0.99431363 |
| 85 | MP0002751_abnormal_autonomic_nervous | 0.95232061 |
| 86 | MP0003633_abnormal_nervous_system | 0.93258419 |
| 87 | MP0004036_abnormal_muscle_relaxation | 0.92156405 |
| 88 | MP0000049_abnormal_middle_ear | 0.91334580 |
| 89 | MP0004133_heterotaxia | 0.90804809 |
| 90 | MP0004085_abnormal_heartbeat | 0.90755924 |
| 91 | MP0003315_abnormal_perineum_morphology | 0.90743408 |
| 92 | MP0001286_abnormal_eye_development | 0.85589921 |
| 93 | MP0002102_abnormal_ear_morphology | 0.84151991 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.84128759 |
| 95 | MP0003718_maternal_effect | 0.83687649 |
| 96 | MP0003632_abnormal_nervous_system | 0.83543153 |
| 97 | MP0008874_decreased_physiological_sensi | 0.81437247 |
| 98 | MP0003011_delayed_dark_adaptation | 0.81371397 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.80828104 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.80748169 |
| 101 | MP0009703_decreased_birth_body | 0.80619978 |
| 102 | MP0003631_nervous_system_phenotype | 0.80118776 |
| 103 | MP0003938_abnormal_ear_development | 0.79263495 |
| 104 | MP0002697_abnormal_eye_size | 0.78025264 |
| 105 | MP0000516_abnormal_urinary_system | 0.75480878 |
| 106 | MP0005367_renal/urinary_system_phenotyp | 0.75480878 |
| 107 | MP0003755_abnormal_palate_morphology | 0.75255323 |
| 108 | MP0005253_abnormal_eye_physiology | 0.73441930 |
| 109 | MP0002081_perinatal_lethality | 0.72653492 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.71872693 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.71030087 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.69860452 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.69717792 |
| 114 | MP0005535_abnormal_body_temperature | 0.69492242 |
| 115 | MP0004885_abnormal_endolymph | 0.68596226 |
| 116 | MP0003121_genomic_imprinting | 0.68264319 |
| 117 | MP0005195_abnormal_posterior_eye | 0.68188158 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.67683854 |
| 119 | MP0000747_muscle_weakness | 0.67168338 |
| 120 | MP0003634_abnormal_glial_cell | 0.67068908 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.66288469 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.65652843 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.63815766 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.63585133 |
| 125 | MP0005187_abnormal_penis_morphology | 0.62811839 |
| 126 | MP0004484_altered_response_of | 0.62325879 |
| 127 | MP0003861_abnormal_nervous_system | 0.62252323 |
| 128 | MP0001943_abnormal_respiration | 0.61169973 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.60213775 |
| 130 | MP0002876_abnormal_thyroid_physiology | 0.58909799 |
| 131 | MP0001177_atelectasis | 0.58095600 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.55140360 |
| 133 | MP0000604_amyloidosis | 0.54547599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.24393515 |
| 2 | Myokymia (HP:0002411) | 6.01313960 |
| 3 | Atonic seizures (HP:0010819) | 5.13364554 |
| 4 | Focal seizures (HP:0007359) | 4.80264235 |
| 5 | Absence seizures (HP:0002121) | 4.79991370 |
| 6 | Febrile seizures (HP:0002373) | 4.53317600 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.46231396 |
| 8 | Visual hallucinations (HP:0002367) | 4.38023930 |
| 9 | Dialeptic seizures (HP:0011146) | 4.08977149 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.98735388 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.93443596 |
| 12 | Spastic diplegia (HP:0001264) | 3.92213619 |
| 13 | Abnormality of the labia minora (HP:0012880) | 3.59622589 |
| 14 | Termporal pattern (HP:0011008) | 3.37733501 |
| 15 | Insidious onset (HP:0003587) | 3.37733501 |
| 16 | Action tremor (HP:0002345) | 3.27886815 |
| 17 | Colon cancer (HP:0003003) | 3.23191166 |
| 18 | Pheochromocytoma (HP:0002666) | 3.22518997 |
| 19 | Limb dystonia (HP:0002451) | 3.22305894 |
| 20 | Ankle clonus (HP:0011448) | 3.20829325 |
| 21 | Hyperventilation (HP:0002883) | 3.11305872 |
| 22 | Exercise-induced muscle cramps (HP:0003710) | 2.97549682 |
| 23 | Hepatoblastoma (HP:0002884) | 2.96419294 |
| 24 | Broad-based gait (HP:0002136) | 2.91917595 |
| 25 | EEG with generalized epileptiform discharges (HP:0011198) | 2.89506229 |
| 26 | Dysdiadochokinesis (HP:0002075) | 2.88928041 |
| 27 | Vaginal atresia (HP:0000148) | 2.88890805 |
| 28 | Anxiety (HP:0000739) | 2.86548283 |
| 29 | Epileptiform EEG discharges (HP:0011182) | 2.86347630 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.82689452 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 2.82474326 |
| 32 | Truncal ataxia (HP:0002078) | 2.81817715 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 2.81778271 |
| 34 | Fetal akinesia sequence (HP:0001989) | 2.80550419 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.80362832 |
| 36 | Nephrogenic diabetes insipidus (HP:0009806) | 2.70730797 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69064469 |
| 38 | Urinary urgency (HP:0000012) | 2.68255591 |
| 39 | Hypothermia (HP:0002045) | 2.65557685 |
| 40 | Hyperglycinemia (HP:0002154) | 2.62659633 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61642265 |
| 42 | Depression (HP:0000716) | 2.61589168 |
| 43 | Mutism (HP:0002300) | 2.59797168 |
| 44 | Drooling (HP:0002307) | 2.57745862 |
| 45 | Excessive salivation (HP:0003781) | 2.57745862 |
| 46 | Abnormality of macular pigmentation (HP:0008002) | 2.52608591 |
| 47 | Poor eye contact (HP:0000817) | 2.52063661 |
| 48 | Septo-optic dysplasia (HP:0100842) | 2.51916606 |
| 49 | Ulnar claw (HP:0001178) | 2.51575103 |
| 50 | Amblyopia (HP:0000646) | 2.51212951 |
| 51 | Progressive inability to walk (HP:0002505) | 2.50736726 |
| 52 | Polyphagia (HP:0002591) | 2.46857095 |
| 53 | Hypsarrhythmia (HP:0002521) | 2.44799735 |
| 54 | Inability to walk (HP:0002540) | 2.44662193 |
| 55 | Split foot (HP:0001839) | 2.43377633 |
| 56 | Gait imbalance (HP:0002141) | 2.42105321 |
| 57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41791198 |
| 58 | Agitation (HP:0000713) | 2.41585816 |
| 59 | Volvulus (HP:0002580) | 2.35866475 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.33849479 |
| 61 | Poor coordination (HP:0002370) | 2.31688989 |
| 62 | Dysmetria (HP:0001310) | 2.31051791 |
| 63 | Impaired social interactions (HP:0000735) | 2.28946416 |
| 64 | Abnormal social behavior (HP:0012433) | 2.28946416 |
| 65 | Spastic gait (HP:0002064) | 2.26110610 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.23920892 |
| 67 | Failure to thrive in infancy (HP:0001531) | 2.23787689 |
| 68 | Central scotoma (HP:0000603) | 2.23700768 |
| 69 | Scanning speech (HP:0002168) | 2.23031714 |
| 70 | Partial agenesis of the corpus callosum (HP:0001338) | 2.21223805 |
| 71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20060404 |
| 72 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20060404 |
| 73 | Nemaline bodies (HP:0003798) | 2.19038557 |
| 74 | Abnormal EKG (HP:0003115) | 2.18795412 |
| 75 | Torticollis (HP:0000473) | 2.18724244 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17372437 |
| 77 | Absent speech (HP:0001344) | 2.17365525 |
| 78 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.16496654 |
| 79 | Hypoplasia of the brainstem (HP:0002365) | 2.16496654 |
| 80 | Genetic anticipation (HP:0003743) | 2.16363423 |
| 81 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15774365 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 2.15471055 |
| 83 | Amniotic constriction ring (HP:0009775) | 2.13885364 |
| 84 | Abnormality of placental membranes (HP:0011409) | 2.13885364 |
| 85 | Methylmalonic acidemia (HP:0002912) | 2.13059874 |
| 86 | Muscle fiber inclusion bodies (HP:0100299) | 2.12471789 |
| 87 | Prolonged QT interval (HP:0001657) | 2.12225533 |
| 88 | Absent septum pellucidum (HP:0001331) | 2.11011387 |
| 89 | Intestinal atresia (HP:0011100) | 2.09132091 |
| 90 | Supernumerary spleens (HP:0009799) | 2.08823328 |
| 91 | Megalencephaly (HP:0001355) | 2.08048333 |
| 92 | Dysmetric saccades (HP:0000641) | 2.06954380 |
| 93 | Myotonia (HP:0002486) | 2.06352869 |
| 94 | Lissencephaly (HP:0001339) | 2.05583184 |
| 95 | Broad foot (HP:0001769) | 2.05109708 |
| 96 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.03844059 |
| 97 | Acute encephalopathy (HP:0006846) | 2.02918432 |
| 98 | Progressive macrocephaly (HP:0004481) | 2.02896178 |
| 99 | Lower limb muscle weakness (HP:0007340) | 2.01181716 |
| 100 | Pendular nystagmus (HP:0012043) | 2.00502683 |
| 101 | Hypoventilation (HP:0002791) | 1.98038610 |
| 102 | Abnormality of glycine metabolism (HP:0010895) | 1.97570467 |
| 103 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97570467 |
| 104 | Shoulder girdle muscle weakness (HP:0003547) | 1.97137228 |
| 105 | Ventricular fibrillation (HP:0001663) | 1.97100110 |
| 106 | Exercise-induced myalgia (HP:0003738) | 1.96916498 |
| 107 | Poor suck (HP:0002033) | 1.95243704 |
| 108 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.93983422 |
| 109 | Specific learning disability (HP:0001328) | 1.93800200 |
| 110 | Anosmia (HP:0000458) | 1.92720175 |
| 111 | Abnormal hair whorl (HP:0010721) | 1.92072883 |
| 112 | Spastic tetraplegia (HP:0002510) | 1.91787109 |
| 113 | Acute necrotizing encephalopathy (HP:0006965) | 1.91490757 |
| 114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90985451 |
| 115 | Focal dystonia (HP:0004373) | 1.90115668 |
| 116 | Congenital primary aphakia (HP:0007707) | 1.89326352 |
| 117 | Abnormality of serum amino acid levels (HP:0003112) | 1.89242256 |
| 118 | Syncope (HP:0001279) | 1.88594103 |
| 119 | Akinesia (HP:0002304) | 1.87791898 |
| 120 | Incomplete penetrance (HP:0003829) | 1.87334171 |
| 121 | Popliteal pterygium (HP:0009756) | 1.86761213 |
| 122 | Esophageal atresia (HP:0002032) | 1.86262445 |
| 123 | Abnormality of salivation (HP:0100755) | 1.85638436 |
| 124 | Optic nerve hypoplasia (HP:0000609) | 1.85635884 |
| 125 | Abnormality of the septum pellucidum (HP:0007375) | 1.83950058 |
| 126 | Craniofacial dystonia (HP:0012179) | 1.83327532 |
| 127 | Broad alveolar ridges (HP:0000187) | 1.82921390 |
| 128 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82775511 |
| 129 | Abnormality of the ileum (HP:0001549) | 1.82431680 |
| 130 | Genital tract atresia (HP:0001827) | 1.81867964 |
| 131 | Retinal dysplasia (HP:0007973) | 1.81620508 |
| 132 | Decreased testicular size (HP:0008734) | 1.80942383 |
| 133 | Postural instability (HP:0002172) | 1.80519289 |
| 134 | Generalized myoclonic seizures (HP:0002123) | 1.80389568 |
| 135 | Meckel diverticulum (HP:0002245) | 1.78972997 |
| 136 | Exotropia (HP:0000577) | 1.77826275 |
| 137 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76804582 |
| 138 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76771131 |
| 139 | Hyperglycinuria (HP:0003108) | 1.76513087 |
| 140 | Psychosis (HP:0000709) | 1.76163168 |
| 141 | Abnormality of pain sensation (HP:0010832) | 1.75642389 |
| 142 | Impaired pain sensation (HP:0007328) | 1.75642389 |
| 143 | Gastrointestinal atresia (HP:0002589) | 1.75189738 |
| 144 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74680016 |
| 145 | Cerebral inclusion bodies (HP:0100314) | 1.74568865 |
| 146 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74461770 |
| 147 | Medial flaring of the eyebrow (HP:0010747) | 1.74385954 |
| 148 | Stenosis of the external auditory canal (HP:0000402) | 1.73871528 |
| 149 | Muscle fiber atrophy (HP:0100295) | 1.72730869 |
| 150 | Depressed nasal tip (HP:0000437) | 1.70773479 |
| 151 | Renal hypoplasia (HP:0000089) | 1.70545892 |
| 152 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70100094 |
| 153 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70100094 |
| 154 | Mitochondrial inheritance (HP:0001427) | 1.68901928 |
| 155 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65408127 |
| 156 | Labial hypoplasia (HP:0000066) | 1.64368159 |
| 157 | Hypoplastic female external genitalia (HP:0012815) | 1.63593974 |
| 158 | Breast aplasia (HP:0100783) | 1.62258069 |
| 159 | Abnormal lung lobation (HP:0002101) | 1.59227556 |
| 160 | Bifid tongue (HP:0010297) | 1.59018270 |
| 161 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.58994162 |
| 162 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.58994162 |
| 163 | Megaloblastic anemia (HP:0001889) | 1.58699637 |
| 164 | Abnormality of the neuromuscular junction (HP:0003398) | 1.58415863 |
| 165 | Fatigable weakness (HP:0003473) | 1.58415863 |
| 166 | Cortical dysplasia (HP:0002539) | 1.58068452 |
| 167 | Neoplasm of the adrenal gland (HP:0100631) | 1.56942710 |
| 168 | Cupped ear (HP:0000378) | 1.56657800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.98836875 |
| 2 | MARK1 | 3.60278095 |
| 3 | MAP3K4 | 3.25043758 |
| 4 | NTRK3 | 3.13160697 |
| 5 | PBK | 3.03194616 |
| 6 | MINK1 | 2.96439973 |
| 7 | MAP2K7 | 2.78946764 |
| 8 | MAP3K12 | 2.76438728 |
| 9 | CASK | 2.74552410 |
| 10 | KSR2 | 2.52792049 |
| 11 | MKNK2 | 2.40539092 |
| 12 | EPHA4 | 2.26178944 |
| 13 | ARAF | 2.19889932 |
| 14 | PAK6 | 2.16046939 |
| 15 | PHKG2 | 2.13833111 |
| 16 | PHKG1 | 2.13833111 |
| 17 | MAP2K4 | 2.12762948 |
| 18 | OBSCN | 2.10359155 |
| 19 | NTRK1 | 2.04211293 |
| 20 | TSSK6 | 1.97800342 |
| 21 | MAPK13 | 1.87373321 |
| 22 | BMPR1B | 1.86658382 |
| 23 | LATS2 | 1.78976595 |
| 24 | KSR1 | 1.77701837 |
| 25 | MKNK1 | 1.68708189 |
| 26 | BUB1 | 1.68635598 |
| 27 | DAPK2 | 1.67826604 |
| 28 | TNIK | 1.66660327 |
| 29 | PLK3 | 1.64884475 |
| 30 | FGFR2 | 1.57974243 |
| 31 | NTRK2 | 1.55824460 |
| 32 | NUAK1 | 1.54291091 |
| 33 | NME1 | 1.54015756 |
| 34 | SRPK1 | 1.51369398 |
| 35 | GRK5 | 1.46723386 |
| 36 | PNCK | 1.45161287 |
| 37 | TRIM28 | 1.43625642 |
| 38 | CDC7 | 1.39472397 |
| 39 | OXSR1 | 1.29300014 |
| 40 | PLK4 | 1.25827733 |
| 41 | MAP3K13 | 1.25391873 |
| 42 | VRK2 | 1.24744336 |
| 43 | LMTK2 | 1.23835512 |
| 44 | CDK5 | 1.22239204 |
| 45 | PLK2 | 1.21678295 |
| 46 | CSNK1G1 | 1.20537260 |
| 47 | GRK7 | 1.18444269 |
| 48 | VRK1 | 1.16027073 |
| 49 | DYRK3 | 1.15860148 |
| 50 | MAP3K6 | 1.12126442 |
| 51 | PRPF4B | 1.11036283 |
| 52 | CSNK1G2 | 1.09096605 |
| 53 | RAF1 | 1.08781725 |
| 54 | NEK1 | 1.07782555 |
| 55 | PAK3 | 1.06198079 |
| 56 | MAP3K2 | 1.01683236 |
| 57 | ZAK | 0.96675803 |
| 58 | CAMK2A | 0.93578529 |
| 59 | TTK | 0.93422541 |
| 60 | FRK | 0.91707692 |
| 61 | RET | 0.91552757 |
| 62 | CDK14 | 0.91120404 |
| 63 | GRK1 | 0.89136159 |
| 64 | PRKCG | 0.87823632 |
| 65 | PLK1 | 0.87652619 |
| 66 | BRAF | 0.86966994 |
| 67 | FGFR1 | 0.86409975 |
| 68 | DYRK2 | 0.86026977 |
| 69 | INSRR | 0.85997267 |
| 70 | CCNB1 | 0.85746791 |
| 71 | TAF1 | 0.85516270 |
| 72 | MAP2K1 | 0.84493563 |
| 73 | DAPK1 | 0.84438546 |
| 74 | CAMK2D | 0.83498744 |
| 75 | CDK18 | 0.83310122 |
| 76 | ERBB3 | 0.80712887 |
| 77 | SGK223 | 0.80522912 |
| 78 | SGK494 | 0.80522912 |
| 79 | CDK15 | 0.80342399 |
| 80 | UHMK1 | 0.77321810 |
| 81 | SIK2 | 0.76140620 |
| 82 | CAMKK1 | 0.76009763 |
| 83 | FES | 0.74616506 |
| 84 | DYRK1A | 0.72690453 |
| 85 | CSNK1G3 | 0.71922401 |
| 86 | STK38 | 0.71831782 |
| 87 | PRKCE | 0.70458542 |
| 88 | FER | 0.69647572 |
| 89 | CDK19 | 0.69071923 |
| 90 | RIPK4 | 0.68872356 |
| 91 | PRKD3 | 0.68307004 |
| 92 | CDK11A | 0.68166998 |
| 93 | SCYL2 | 0.67875433 |
| 94 | LIMK1 | 0.67098525 |
| 95 | CSNK1E | 0.64706760 |
| 96 | MAP3K1 | 0.63813549 |
| 97 | MAPKAPK3 | 0.63082363 |
| 98 | BMPR2 | 0.62123362 |
| 99 | CAMKK2 | 0.61318119 |
| 100 | MOS | 0.57217667 |
| 101 | LATS1 | 0.56476970 |
| 102 | MARK2 | 0.55079109 |
| 103 | SGK2 | 0.54588971 |
| 104 | ALK | 0.54364357 |
| 105 | WNK3 | 0.53413738 |
| 106 | ADRBK1 | 0.53092013 |
| 107 | MUSK | 0.52925060 |
| 108 | RPS6KA4 | 0.52622977 |
| 109 | EIF2AK3 | 0.51655328 |
| 110 | PINK1 | 0.50595442 |
| 111 | RPS6KA2 | 0.49594697 |
| 112 | WNK1 | 0.48541154 |
| 113 | PRKG1 | 0.48418402 |
| 114 | ADRBK2 | 0.47783144 |
| 115 | STK11 | 0.47735221 |
| 116 | CAMK2B | 0.46348820 |
| 117 | TGFBR1 | 0.45768484 |
| 118 | STK16 | 0.45164644 |
| 119 | MAP4K2 | 0.44797877 |
| 120 | TAOK1 | 0.44769105 |
| 121 | ATM | 0.44041994 |
| 122 | BCR | 0.43006947 |
| 123 | PRKDC | 0.42919337 |
| 124 | PRKACB | 0.41869775 |
| 125 | CDK8 | 0.41401437 |
| 126 | MAPKAPK5 | 0.41224100 |
| 127 | MAP3K7 | 0.41192062 |
| 128 | CAMK2G | 0.40856718 |
| 129 | AKT3 | 0.40812670 |
| 130 | CSNK1A1L | 0.40778276 |
| 131 | CSNK1D | 0.40763621 |
| 132 | PRKCZ | 0.39953082 |
| 133 | DYRK1B | 0.39017144 |
| 134 | PRKAA1 | 0.38681870 |
| 135 | ROCK2 | 0.37556330 |
| 136 | PRKCH | 0.36250989 |
| 137 | PRKACA | 0.35993940 |
| 138 | STK38L | 0.35978074 |
| 139 | PDK4 | 0.35490588 |
| 140 | PDK3 | 0.35490588 |
| 141 | CDK3 | 0.35080956 |
| 142 | TIE1 | 0.34861849 |
| 143 | TNK2 | 0.33958095 |
| 144 | CAMK1 | 0.33563201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.75591302 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.32582438 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.07077201 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.86036673 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72103479 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.55196654 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41064381 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.27073406 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.24689109 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.14835544 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06876130 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05153080 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.02194638 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97212851 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.94734937 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88067728 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.82333899 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.81352700 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.76689085 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75518486 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.67850657 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.62833219 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60552738 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58237850 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.56402049 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.56210640 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52288277 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51221053 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.51116109 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50736647 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.46723441 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.41277831 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40918799 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.40599713 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.40451716 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40378055 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39883768 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38131777 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34588075 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.32171892 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31623465 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29628754 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.29546517 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.28448242 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.28136813 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27826007 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27237305 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24572748 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20840475 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14157159 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12664916 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.10781617 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08746305 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08558100 |
| 55 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08544982 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08436427 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07994925 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07058448 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04494188 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01903957 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.00323848 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98948115 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98409682 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97803764 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95465218 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94337845 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.94221499 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92380004 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90805775 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.90593385 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90430225 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90358791 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89930184 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.89602476 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88816837 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88656864 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87143989 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85242009 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.85041656 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84893938 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84506376 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83200290 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.82098083 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81513236 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78395499 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76513105 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75797755 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74798007 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74532527 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73357689 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71626952 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71312960 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71085026 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.70358494 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.70317321 |
| 96 | Ribosome_Homo sapiens_hsa03010 | 0.69568272 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69187105 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68858075 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67808185 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.67505893 |
| 101 | DNA replication_Homo sapiens_hsa03030 | 0.67329614 |
| 102 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66460055 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66298786 |
| 104 | Base excision repair_Homo sapiens_hsa03410 | 0.64740220 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64246725 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63640705 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63588733 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63015936 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62806220 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62358781 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62129980 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61470429 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60892445 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60723758 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59516870 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58644271 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58039057 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56595895 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55316292 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54010221 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53917042 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53584412 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52837016 |
| 124 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52065422 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51765280 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50723459 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50352568 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49743197 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49520856 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49426865 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49209585 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47668795 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47506096 |
| 134 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47335421 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46718002 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46367687 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45951758 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45191767 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44678575 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44567532 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.44565793 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44027620 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43869547 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42712060 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42072955 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37775821 |
| 147 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37522004 |
| 148 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35836531 |
| 149 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35238440 |
| 150 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34962222 |
| 151 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34929945 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33017506 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32757528 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32258789 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31935116 |

